Oric Pharma grants 161,550 inducement stock options to new hires under 2022 plan
ORIC•Oric Pharmaceuticals granted 161,550 stock options and 26,850 restricted stock units to six new non-executive hires on Oct. 1, 2026, under its 2022 Inducement Equity Incentive Plan.
1. Equity awards granted
The options have an exercise price set at the stock’s closing price on the grant date. One-quarter of the options vest after one year, with the remainder vesting monthly over the following 36 months; the restricted stock units vest in equal thirds on the first three anniversaries of the grant date.
